LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 93.96 | 27.76 | 1004 | 6849 | 0.1466 | 0.5707 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 93.96 | 27.76 | 1189 | 6849 | 0.1736 | 0.6045 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 93.96 | 27.76 | 1200 | 6849 | 0.1752 | 0.6064 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 95.66 | 27.76 | 989 | 6712 | 0.1473 | 0.5703 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 95.66 | 27.76 | 1012 | 6712 | 0.1508 | 0.5749 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 95.66 | 27.76 | 1187 | 6712 | 0.1768 | 0.6069 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 95.66 | 27.76 | 1198 | 6712 | 0.1785 | 0.6088 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 1.95 | 27.76 | 596 | 225 | 2.6472 | 1.7608 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 1.95 | 27.76 | 636 | 225 | 2.8249 | 1.8208 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 3.66 | 27.76 | 634 | 283 | 2.2330 | 1.5412 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 3.66 | 27.76 | 681 | 283 | 2.3985 | 1.5959 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 5.36 | 27.76 | 711 | 320 | 2.2194 | 1.5070 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 5.36 | 27.76 | 2 | 320 | 0.0062 | -0.5255 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 5.36 | 27.76 | 792 | 320 | 2.4722 | 1.5848 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 7.06 | 27.76 | 2 | 360 | 0.0056 | -0.5091 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 7.06 | 27.76 | 779 | 360 | 2.1639 | 1.4644 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 7.06 | 27.76 | 2 | 360 | 0.0056 | -0.5091 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 7.06 | 27.76 | 864 | 360 | 2.4000 | 1.5344 | MN20160318_Q01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 8.76 | 27.76 | 4 | 401 | 0.0100 | -0.3952 | MN20160318_Q01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 8.76 | 27.76 | 817 | 401 | 2.0367 | 1.4055 | MN20160318_Q01 | E15 |